A story in the New York Times concerns efforts by federal regulators to develop a stronger label for the diabetes drug Byetta, manufactured by Eli Lilly, following more reports of deadly pancreatitis.
The U.S. Food and Drug Administration reported an additional six cases of pancreatitis. Two of the patients died and four were recovering.
An earlier FDA alert cited about 30 reports of Byetta patients developing a dangerous form of pancreatitis, which ...
continue reading...